Liaoning Chengda Biotechnology Co. Ltd. Class ASSE: 688739

Announcement on Obtaining the Approval for Supplementary Application for Drugs for the Core Product Freeze-dried Rabies Vaccine (Vero Cells)

· Issued by Liaoning Chengda Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining the Approval for Supplementary Application for Drugs for the Core Product Freeze-dried Rabies Vaccine (Vero Cells)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis